Paid Clinical Trials in Annapolis, MD
As of August 2026, 36 paid clinical trials are recruiting in Annapolis, Maryland. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Annapolis offers studies at sites including Luminis Health Anne Arundel Medical Center for conditions such as Breast Cancer, Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Annapolis
Trials by drug in Annapolis
Filter results
Newly added in Annapolis
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
36 clinical trials
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Prospective Study to Assess a Diagnostic Aid for Cancer
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Long-Term Stability of the Glide Control Strategy
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Top Research Study Locations in Annapolis
Researchers run research studies in Annapolis, MD at 23 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Luminis Health Anne Arundel Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 3 |
| Maryland Oncology Hematology, P.A. | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 3 |
| Anne Arundel Urology | Benign Prostatic Hyperplasia, High-Risk Non-Muscle-Invasive Bladder Cancer, Overactive Bladder | 2 |
| Anne Arundel Urology, PA | Intermediate Risk Non-Muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 2 |
| Maryland Oncology Hematology | Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 2 |
| Velocity Clinical Research | Breast Cancer, Cancer | 2 |
| Anna Arundel Urology | Non-muscle-invasive Bladder Cancer | 1 |
| Annapolis Internal Medicine - CCT Research | Coronavirus Disease (COVID-19) | 1 |
| Anne Arundel Health System | Fallopian Tube Neoplasms, High Grade Ovarian Serous Adenocarcinoma, Ovarian Epithelial Carcinoma | 1 |
| Clearway Pain Solutions | Lumbar Spinal Stenosis | 1 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| Local Institution - 0505 | Non-small Cell Lung Cancer | 1 |
| Local Institution - 0702 | Carcinoma, Non-Small-Cell Lung | 1 |
| Luminis Health Center for Cancer & Blood Disorders | Breast Cancer | 1 |
| Maryland Oncology Hematology P.A. | Breast Cancer | 1 |
| Medical Center Orthotics and Prosthetics - Annapolis | Upper Limb Amputation Above Elbow, Upper Limb Amputation Below Elbow | 1 |
| Medstar Surg Ctr At Annapolis | Lumbar Spinal Stenosis | 1 |
| Research | Hypertriglyceridemia | 1 |
| Riva Road Surgery Center | Lumbar Spinal Stenosis | 1 |
| SCRI - Maryland Oncology Hematology, P.A. | Endometrioid Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer | 1 |
| US Naval Health Clinic (Academy) | Anterior Shoulder Dislocation, Glenohumeral Dislocation, Shoulder Dislocation | 1 |
| Velocity Clinical Research, Annapolis | Symptomatic Venous Thromboembolism (VTE) | 1 |
Active & Upcoming Studies in Annapolis (2026)
Recruiting trials in Annapolis grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (24 active studies)
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
Vaccines (1 active study)
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
Mental health & behavior (1 active study)
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
Diabetes & metabolic (1 active study)
Neurology & pain (1 active study)
Common conditions studied in Annapolis
- Breast Cancer (5 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
- Non-Small Cell Lung Cancer (2 active studies)
- Advanced Non-Small Cell Lung Cancer (1 active study)
- Anatomic Stage II Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (1 active study)
Leading research sponsors in Annapolis
- AstraZeneca
- Pfizer
- Ferring Pharmaceuticals
- Hoffmann-La Roche
- Agendia
Frequently asked questions
How many paid clinical trials are currently recruiting in Annapolis?
There are approximately 36 recruiting clinical trials in Annapolis, Maryland listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Annapolis pay participants?
Most recruiting trials in Annapolis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Annapolis?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Annapolis?
The most common conditions under active study in Annapolis include Breast Cancer (5), Carcinoma, Non-Small-Cell Lung (2), Non-Small Cell Lung Cancer (2), Advanced Non-Small Cell Lung Cancer (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Annapolis?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Annapolis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Annapolis?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Annapolis?
Recruiting research sites in Annapolis include Luminis Health Anne Arundel Medical Center, Maryland Oncology Hematology, P.A., Anne Arundel Urology, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Annapolis right now?
The largest active categories in Annapolis are Cancer & tumors (24), Vaccines (1), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.